Outcome of Separate Meeting of Independent Directors held on March 24, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genpharmasec Ltd informed the stock exchange that its Independent Directors held a separate meeting on March 24, 2026, from 11:00 AM to 11:30 AM, as required under the Companies Act, 2013 and SEBI Listing Regulations. During the meeting, the Independent Directors reviewed the performance of Non-Independent Directors and the Board as a whole, reviewed the performance of the Chairperson, and assessed the quality, quantity and timeliness of information flow between management and the Board. The outcome was signed by Mr. Siddhesh Shende, Independent Director. No material decisions or financial details were disclosed.
This is a routine corporate governance compliance filing with no direct impact on shareholders or stock price. It simply confirms that the company's Independent Directors met to carry out their annual performance review duties as mandated by regulations.